Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) was the sixth common malignancies characteristic with highly aggressive in the world. It was well established that tumor mutation burden (TMB) act as indicator of immunotherapeutic responsiveness in various tumors. However, the role of TMB in tumor immune m...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Qianhui, Xu, Hao, Deng, Rongshan, Wang, Zijie, Li, Nanjun, Qi, Zhixuan, Zhao, Jiaxin, Huang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254981/
https://www.ncbi.nlm.nih.gov/pubmed/34217320
http://dx.doi.org/10.1186/s12935-021-02049-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254981/
https://www.ncbi.nlm.nih.gov/pubmed/34217320
http://dx.doi.org/10.1186/s12935-021-02049-w

Ejemplares similares